{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:43:22Z","timestamp":1740149002928,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100012248","name":"Collaborative Innovation Center for Modern Science and Technology and Industrial Development of Jiangxi Traditional Medicine","doi-asserted-by":"publisher","award":["2018ZYX02"],"award-info":[{"award-number":["2018ZYX02"]}],"id":[{"id":"10.13039\/501100012248","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2021JJ80061"],"award-info":[{"award-number":["2021JJ80061"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"name":"General Research Project of Hunan Provincial Health Commission","award":["202213055560"],"award-info":[{"award-number":["202213055560"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s12325-022-02297-w","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T04:04:35Z","timestamp":1661918675000},"page":"5043-5057","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Effectiveness of Chemoradiotherapy in Elderly Patients with Pancreatic Cancer: A Population-Based Study Based on the SEER Database"],"prefix":"10.1007","volume":"39","author":[{"given":"Duorui","family":"Nie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqi","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,31]]},"reference":[{"doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330.","key":"2297_CR1","DOI":"10.3322\/caac.21590"},{"issue":"5","key":"2297_CR2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.trecan.2017.04.005","volume":"3","author":"LE Oldfield","year":"2017","unstructured":"Oldfield LE, Connor AA, Gallinger S. Molecular events in the natural history of pancreatic cancer. Trends Cancer. 2017;3(5):336\u201346.","journal-title":"Trends Cancer"},{"key":"2297_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2018.10.013","volume":"72","author":"M Macchini","year":"2019","unstructured":"Macchini M, Chiaravalli M, Zanon S, et al. Chemotherapy in elderly patients with pancreatic cancer: efficacy, feasibility and future perspectives. Cancer Treat Rev. 2019;72:1\u20136.","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"2297_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/SLA.0b013e3180691579","volume":"246","author":"KY Bilimoria","year":"2007","unstructured":"Bilimoria KY, Bentrem DJ, Ko CY, et al. National failure to operate on early stage\u00a0pancreatic cancer. Ann Surg. 2007;246(2):173\u201380.","journal-title":"Ann Surg"},{"issue":"8","key":"2297_CR5","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1245\/ASO.2006.08.011","volume":"13","author":"GR Varadhachary","year":"2006","unstructured":"Varadhachary GR, Tamm EP, Abbruzzese JL, et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol. 2006;13(8):1035\u201346.","journal-title":"Ann Surg Oncol"},{"issue":"21","key":"2297_CR6","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1200\/JCO.2016.67.5553","volume":"34","author":"AA Khorana","year":"2016","unstructured":"Khorana AA, Mangu PB, Berlin J, et al. Potentially curable pancreatic cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016;34(21):2541\u201356.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2297_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399\u2013424.","journal-title":"Multivar Behav Res"},{"issue":"3","key":"2297_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.21037\/atm.2016.08.62","volume":"5","author":"Z Zhang","year":"2017","unstructured":"Zhang Z. Survival analysis in the presence of competing risks. Ann Transl Med. 2017;5(3):47.","journal-title":"Ann Transl Med"},{"doi-asserted-by":"crossref","unstructured":"Tempero MA, Malafa MP, Al-Hawary M, et al. Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(4):439\u201357.","key":"2297_CR9","DOI":"10.6004\/jnccn.2021.0017"},{"issue":"2","key":"2297_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/jso.24630","volume":"116","author":"LM Youngwirth","year":"2017","unstructured":"Youngwirth LM, Nussbaum DP, Thomas S, et al. Nationwide trends and outcomes associated with neoadjuvant therapy in pancreatic cancer: an analysis of 18 243 patients. J Surg Oncol. 2017;116(2):127\u201332.","journal-title":"J Surg Oncol"},{"issue":"19","key":"2297_CR11","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817\u201325.","journal-title":"N Engl J Med"},{"doi-asserted-by":"crossref","unstructured":"Goldstein D, El-Maraghi RH, Hammel P, et al. nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial. J Natl Cancer Inst. 2015;107(2):dju413.","key":"2297_CR12","DOI":"10.1093\/jnci\/dju413"},{"doi-asserted-by":"crossref","unstructured":"Gillen S, Schuster T, Meyer Zum Buschenfelde C, et al. Preoperative\/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med. 2010;7(4):e1000267.","key":"2297_CR13","DOI":"10.1371\/journal.pmed.1000267"},{"issue":"1","key":"2297_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12957-017-1240-2","volume":"15","author":"M Dhir","year":"2017","unstructured":"Dhir M, Malhotra GK, Sohal DPS, et al. Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients. World J Surg Oncol. 2017;15(1):183.","journal-title":"World J Surg Oncol"},{"issue":"8","key":"2297_CR15","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/bjs.10870","volume":"105","author":"E Versteijne","year":"2018","unstructured":"Versteijne E, Vogel JA, Besselink MG, et al. Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer. Br J Surg. 2018;105(8):946\u201358.","journal-title":"Br J Surg"},{"issue":"8","key":"2297_CR16","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1093\/jnci\/djz073","volume":"111","author":"QP Janssen","year":"2019","unstructured":"Janssen QP, Buettner S, Suker M, et al. Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis. J Natl Cancer Inst. 2019;111(8):782\u201394.","journal-title":"J Natl Cancer Inst"},{"key":"2297_CR17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/1748-717X-8-240","volume":"8","author":"CH Kim","year":"2013","unstructured":"Kim CH, Ling DC, Wegner RE, et al. Stereotactic body radiotherapy in the treatment of pancreatic adenocarcinoma in elderly patients. Radiat Oncol. 2013;8:240.","journal-title":"Radiat Oncol"},{"issue":"2","key":"2297_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/COC.0000000000000118","volume":"40","author":"MK Gurka","year":"2017","unstructured":"Gurka MK, Kim C, He AR, et al. Stereotactic body radiation therapy (SBRT) combined with chemotherapy for unresected pancreatic adenocarcinoma. Am J Clin Oncol. 2017;40(2):152\u20137.","journal-title":"Am J Clin Oncol"},{"key":"2297_CR19","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.2147\/CMAR.S163655","volume":"10","author":"X Zhu","year":"2018","unstructured":"Zhu X, Li F, Liu W, et al. Stereotactic body radiation therapy plus induction or adjuvant chemotherapy for early stage\u00a0but medically inoperable pancreatic cancer: a propensity score-matched analysis of a prospectively collected database. Cancer Manag Res. 2018;10:1295\u2013304.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"2297_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12885-020-6690-1","volume":"20","author":"J Garnier","year":"2020","unstructured":"Garnier J, Ewald J, Marchese U, et al. Outcomes of patients with initially locally advanced pancreatic adenocarcinoma who did not benefit from resection: a prospective cohort study. BMC Cancer. 2020;20(1):203.","journal-title":"BMC Cancer"},{"doi-asserted-by":"crossref","unstructured":"Sugumar K, Hue JJ, Hardacre JM, et al. Combined multiagent chemotherapy and radiotherapy is associated with prolonged overall survival in patients with non-operatively managed stage\u00a0II-III pancreatic adenocarcinoma. HPB (Oxford). 2022;24(4):433\u201342.","key":"2297_CR21","DOI":"10.1016\/j.hpb.2021.08.938"},{"key":"2297_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.659987","volume":"11","author":"X Ji","year":"2021","unstructured":"Ji X, Zhao Y, He C, et al. Clinical effects of stereotactic body radiation therapy targeting the primary tumor of liver-only oligometastatic pancreatic cancer. Front Oncol. 2021;11:659987.","journal-title":"Front Oncol"},{"doi-asserted-by":"crossref","unstructured":"Vorobyov N, Rykov I, Orlova R, et al. Chemotherapy in combination with stereotactic body radiation therapy (SBRT) for oligometastatic pancreatic cancer. BMJ Case Rep. 2018;2018:bcr2018225846.","key":"2297_CR23","DOI":"10.1136\/bcr-2018-225846"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02297-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-022-02297-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02297-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T15:43:43Z","timestamp":1664552623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-022-02297-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,31]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["2297"],"URL":"https:\/\/doi.org\/10.1007\/s12325-022-02297-w","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"type":"print","value":"0741-238X"},{"type":"electronic","value":"1865-8652"}],"subject":[],"published":{"date-parts":[[2022,8,31]]},"assertion":[{"value":"22 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}